Unique and synergistic roles for 17β-estradiol and macrophage migration inhibitory factor during cutaneous wound closure are cell type specific

Elaine Emmerson, Laura Campbell, Gillian S. Ashcroft, Matthew J. Hardman

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The cutaneous wound healing response is complex, comprising numerous overlapping events including inflammation, fibroblast migration, reepithelialization, and wound contraction. With increased age and resultant reduced systemic estrogens, these processes are disrupted and delayed healing ensues.Wehave demonstrated previously that the proinflammatory cytokine macrophage migration inhibitory factor (MIF) acts as a global regulator of wound healing mediating the majority of estrogen's healing promoting activity. MIF is expressed by numerous wound cell types yet the interaction between estrogens and MIF at the cellular level is still poorly understood. In this studywedemonstrate novel accelerated healing in MIF null mice using an excisionalwoundmodel. Moreover, we show cell-type-specific differences in the effects of 17β-estradiol and/or MIF on the cellular function of a range of wound cell types in vitro. Intriguingly, 17β-estradiol is able to promote the migration of all cell types studied indicating a clear role for cell migration in accelerated wound healing. Copyright © 2009 by The Endocrine Society.
    Original languageEnglish
    Pages (from-to)2749-2757
    Number of pages8
    JournalEndocrinology
    Volume150
    Issue number6
    DOIs
    Publication statusPublished - Jun 2009

    Fingerprint

    Dive into the research topics of 'Unique and synergistic roles for 17β-estradiol and macrophage migration inhibitory factor during cutaneous wound closure are cell type specific'. Together they form a unique fingerprint.

    Cite this